Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 828,142 | 821,000 | 717,848 | 825,940 | 788,213 |
| Cost of Goods | 342,248 | 339,000 | 305,570 | 336,805 | 322,625 |
| Gross Profit | 485,893 | 482,000 | 411,278 | 489,135 | 465,588 |
| Operating Expenses | 271,084 | 267,000 | 273,820 | 289,555 | 264,625 |
| Operating Income | 215,058 | 215,000 | 138,028 | 200,385 | 201,588 |
| Interest Expense | 4,249 | 5,000 | 4,038 | 5,100 | 3,863 |
| Other Income | 19,499 | 15,000 | 14,202 | 4,136 | 3,663 |
| Pre-tax Income | 230,308 | 225,000 | 148,191 | 199,421 | 201,388 |
| Income Tax | 52,167 | 54,000 | 41,438 | 47,275 | 62,288 |
| Net Income Continuous | 178,142 | 171,000 | 106,754 | 152,146 | 139,100 |
| Net Income | $178,142 | $171,000 | $106,754 | $152,146 | $139,100 |
| EPS Basic Total Ops | 0.21 | 0.20 | 0.13 | 0.18 | 0.17 |
| EPS Basic Continuous Ops | 0.21 | 0.20 | 0.13 | 0.18 | 0.17 |
| EPS Diluted Total Ops | 0.21 | 0.20 | 0.13 | 0.18 | 0.17 |
| EPS Diluted Continuous Ops | 0.21 | 0.20 | 0.13 | 0.18 | 0.17 |
| EBITDA(a) | $261,058 | $258,000 | $179,028 | $238,385 | $238,588 |